Mutational profiling of non-small-cell lung cancer patients resistant to first-generation EGFR tyrosine kinase inhibitors using next generation sequencing

Những quyển sách tương tự

• Next-Generation EGFR Tyrosine Kinase Inhibitors for Treating EGFR-Mutant Lung Cancer beyond First Line
  Bằng: Sullivan, Ivana, et al.
  Được phát hành: (2017)
• Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors
  Bằng: Westover, D, et al.
  Được phát hành: (2018)
• Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations
  Bằng: Arrieta, Oscar, et al.
  Được phát hành: (2020)
• Update on third-generation EGFR tyrosine kinase inhibitors
  Bằng: Gray, Jhanelle, et al.
  Được phát hành: (2014)
• Patients harboring EGFR mutation after primary resistance to crizotinib and response to EGFR-tyrosine kinase inhibitor
  Bằng: Wang, Wenxian, et al.
  Được phát hành: (2016)